STI CEO Appointed to BioNova's Board of Directors
Steve Nicolle brings new outlook to Nova Scotia's Life Sciences Sector
HALIFAX, Sept. 12, 2013 /CNW/ - STI, the leader in intelligent reimbursement solutions for the Canadian healthcare market, is pleased to announce the appointment of STI CEO, Steve Nicolle, to the BioNova Board of Directors.
The executive of the Halifax-based company joined the local life sciences organization in late August, bringing with him ten years of CEO and Board-level experience at New England venture-backed technology companies, in addition to his knowledge and experience in his CEO role at STI since 2010.
"We are pleased to welcome Steve to the BioNova Board," says Marli MacNeil, CEO of BioNova. "Steve's background and current position with STI will allow him to bring a unique perspective to the Board."
STI has a proven reputation in the life sciences community of bringing innovation to BioTech companies; their customers include the major pharmaceutical manufacturers in Canada. Founded in 2002, they have been an influential solution provider to the Canadian pharmaceutical industry for over the past ten years.
"We seldom find a CEO who commands instant credibility and trust from international venture capital and strategic investors, Steve has that unique ability," says Brian Bloom, President at Bloom Burton & Co. "We think this is a great opportunity for Nova Scotia to benefit from his experience, knowledge and approach to getting things done."
SOURCE STI Technologies LimitedFor further information:
Mary Jane Leslie